DE69534624D1 - Gentranscripte von MHC Klasse I HLA-G und deren Verwendungen - Google Patents

Gentranscripte von MHC Klasse I HLA-G und deren Verwendungen

Info

Publication number
DE69534624D1
DE69534624D1 DE69534624T DE69534624T DE69534624D1 DE 69534624 D1 DE69534624 D1 DE 69534624D1 DE 69534624 T DE69534624 T DE 69534624T DE 69534624 T DE69534624 T DE 69534624T DE 69534624 D1 DE69534624 D1 DE 69534624D1
Authority
DE
Germany
Prior art keywords
hla
mhc class
gene transcripts
transcripts
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69534624T
Other languages
English (en)
Other versions
DE69534624T2 (de
Inventor
Edgardo Delfino Carosella
Philippe Moreau
Eliane Gluckman
Marek Kirszenbaum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Application granted granted Critical
Publication of DE69534624D1 publication Critical patent/DE69534624D1/de
Publication of DE69534624T2 publication Critical patent/DE69534624T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69534624T 1994-03-18 1995-03-17 Transkripte des HLA-G-Gens des Haupthistokompatibilitätskomplexes (MHC)-Klasse 1 und ihre Anwendungen Expired - Lifetime DE69534624T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403179A FR2717498B1 (fr) 1994-03-18 1994-03-18 Transcrits du gène de CMH de classe I HLA-G et leurs applications.
FR9403179 1994-03-18

Publications (2)

Publication Number Publication Date
DE69534624D1 true DE69534624D1 (de) 2005-12-29
DE69534624T2 DE69534624T2 (de) 2006-08-03

Family

ID=9461181

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69534624T Expired - Lifetime DE69534624T2 (de) 1994-03-18 1995-03-17 Transkripte des HLA-G-Gens des Haupthistokompatibilitätskomplexes (MHC)-Klasse 1 und ihre Anwendungen

Country Status (4)

Country Link
US (3) US5856442A (de)
EP (1) EP0677582B1 (de)
DE (1) DE69534624T2 (de)
FR (1) FR2717498B1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717498B1 (fr) * 1994-03-18 1996-05-03 Commissariat Energie Atomique Transcrits du gène de CMH de classe I HLA-G et leurs applications.
FR2760023B1 (fr) 1997-02-21 2004-05-07 Commissariat Energie Atomique Cellules eucaryotes exprimant a leur surface au moins une isoforme d'hla-g et leurs applications
EP1054688B1 (de) * 1998-02-20 2004-06-30 Commissariat A L'energie Atomique Auswahlverfahren von hla-g exprimierenden tumoren, die durch antikrebsmittel behandelbar sind, und deren verwendungen
FR2775189B1 (fr) * 1998-07-24 2001-06-08 Commissariat Energie Atomique Compositions anti-tumorales a base d'antigenes hla-g ou d'anticorps anti-hla-g
EP1056886A1 (de) * 1998-02-25 2000-12-06 National University of Ireland, Cork Hla-verbundene pre-eclampsia und fehlgeburt empfindlichkeitsgen
FR2794977B1 (fr) * 1999-06-18 2003-10-31 Commissariat Energie Atomique Utilisation de compositions contenant des formes solubles d'hla-g dans le traitement de pathologies inflammatoires de la peau, et leur procede d'obtention
CN1333239A (zh) * 2000-07-07 2002-01-30 上海博德基因开发有限公司 一种新的多肽——人ⅲ型主要组织相容性蛋白复合物61和编码这种多肽的多核苷酸
US20040044182A1 (en) * 2001-09-17 2004-03-04 Hunt Joan S Expression, preparation,uses, and sequence of recombinantly-derived soluble hla-g
WO2003051834A2 (en) * 2001-12-14 2003-06-26 President And Fellows Of Harvard College Immunocellular receptors related to neurological disorders
FR2856599A1 (fr) * 2003-06-30 2004-12-31 Commissariat Energie Atomique Utilisation de compositions contenant une forme soluble d'hla-g dans le traitement de pathologies du sang.
WO2005075669A1 (en) * 2004-02-09 2005-08-18 Universität Bonn Reverse transcription based method for detecting gene expression in a cell
US9216212B2 (en) * 2005-08-05 2015-12-22 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
US7951384B2 (en) * 2005-08-05 2011-05-31 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
EP2184297A1 (de) 2008-11-07 2010-05-12 Hla-G Technologies HLA-G-Polypeptide und pharmazeutische Verwendungen davon
EP2184070A1 (de) 2008-11-07 2010-05-12 Hla-G Technologies HLA-G-Proteine und pharmazeutische Verwendungen davon
EP2264067A1 (de) 2009-06-18 2010-12-22 Hla-G Technologies HLA-G alpha 1 Multimere und pharmazeutische Verwendung davon
JP5736368B2 (ja) 2009-06-25 2015-06-17 コミッサリア ア レネルジ アトミック エ オー エネルジ アルターネイティブスＣｏｍｍｉｓｓａｒｉａｔ Ａ Ｌ’Ｅｎｅｒｇｉｅ Ａｔｏｍｉｑｕｅ Ｅｔ Ａｕｘ Ｅｎｅｒｇｉｅｓ Ａｌｔｅｒｎａｔｉｖｅｓ 少なくとも２つのα３ドメインを含むＨＬＡ−Ｇの多量体ポリペプチド及び医薬としてのその使用
FR2953023B1 (fr) 2009-11-23 2011-12-09 Commissariat Energie Atomique Utilisation d'une isoforme d'hla-g comme marqueur de l'osteogenese
FR2967579B1 (fr) 2010-11-23 2013-11-22 Ets Francais Du Sang Utilisation d'une isoforme d'hla-g comme agent anti-resorption osseuse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043272A (en) * 1989-04-27 1991-08-27 Life Technologies, Incorporated Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers
FR2717498B1 (fr) * 1994-03-18 1996-05-03 Commissariat Energie Atomique Transcrits du gène de CMH de classe I HLA-G et leurs applications.

Also Published As

Publication number Publication date
EP0677582B1 (de) 2005-11-23
DE69534624T2 (de) 2006-08-03
US5856442A (en) 1999-01-05
US6291659B1 (en) 2001-09-18
US20020052487A1 (en) 2002-05-02
FR2717498B1 (fr) 1996-05-03
FR2717498A1 (fr) 1995-09-22
EP0677582A1 (de) 1995-10-18

Similar Documents

Publication Publication Date Title
DE69534624D1 (de) Gentranscripte von MHC Klasse I HLA-G und deren Verwendungen
DE69431285D1 (de) Herstellungsmethode von markierten genen; transcripten und proteinen
DE59800980D1 (de) Mischungen von Reaktivfarbstoffen und deren Verwendung
DE69325577D1 (de) Mn-gen und protein
ATE244005T1 (de) Weitere therapeutische verwendungen von l- methionine und zusammensetzungen
DE59507427D1 (de) Mischkristalle und feste Lösungen von 1,4-Diketopyrrolopyrrolen
DE69510920D1 (de) Galaktomannan-produkte und diese enthaltende zusammensetzungen
FI970352A (fi) MHC-luokan I -raskasketjuekspression vähenemiseen osaaottavan ihmisen sytomegaloviruksen geenin tunnistus
IS5510A (is) Efnasambönd sem verka gegn "picorna"-veirum og aðferðir til nota þeirra og smíða
KR950702113A (ko) 분자 인식 물질로써 아미니미드 함유 분자와 물질(aminimide-containing molecules and materials as molecular recognition agents)
DE69513307D1 (de) Zusammensetzung und verwendung
DE59708905D1 (de) Injektionsformulierungen von avermectinen und milbemycinen
DE69313073D1 (de) Lanolin fettsäure, ihre abtrennung, und kosmetische- und äusserlich anzuwendende zubereitung
DE59606486D1 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69517352D1 (de) Kosmetische Tensid-Präparate und deren Verwendung
DE69533739D1 (de) Herstellung von Triorganozinn-Lithium-Zusammensetzungen und deren Verwendung als Initiatoren
DE69732436D1 (de) Sirupe sowie daraus hergestellte eine emulsion enthaltende umhuellungen
DE69532106D1 (de) Maltose Phospharylase, Trehalose Phophorylase, Plesiomonasstamm, und Herstellung von Trehalose
DE69417164D1 (de) Spender und dessen Verwendungsverfahren
DE59909860D1 (de) Anwendung von 5'-modifizierten nukleotiden in der molekularbiologie und medizin
DE69433639D1 (de) Streckung von Haaren unter Verwendung von Zusammensetzungen enthaltend Keratinreduzierende Substanzen und Alkohole
DE69535981D1 (de) Reovirus Stamm 2177 und diesen enthaltende Vakzine
IT1273540B (it) Fosfiti-hals e fosforammidi-hals come stabilizzanti
DE59511015D1 (de) Schutz- bzw. ankergruppen und deren verwendung (carbamide)
DE69532881D1 (de) Ecdn - protein und dafuer kodeierende dna

Legal Events

Date Code Title Description
8364 No opposition during term of opposition